139 related articles for article (PubMed ID: 15531478)
21. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
22. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
23. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.
Anlauf M; Perren A; Klöppel G
Pathobiology; 2007; 74(5):279-84. PubMed ID: 17890894
[TBL] [Abstract][Full Text] [Related]
24. Identical clonality of sporadic gastrinomas at multiple sites.
Goebel SU; Vortmeyer AO; Zhuang Z; Serrano J; Jensen RT; Lubensky IA
Cancer Res; 2000 Jan; 60(1):60-3. PubMed ID: 10646853
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan.
Kawamura J; Shimada Y; Komoto I; Okamoto H; Itami A; Doi R; Fujimoto K; Kosugi S; Imamura M
Oncol Rep; 2005 Jul; 14(1):47-52. PubMed ID: 15944766
[TBL] [Abstract][Full Text] [Related]
26. Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.
Lopez CL; Falconi M; Waldmann J; Boninsegna L; Fendrich V; Goretzki PK; Langer P; Kann PH; Partelli S; Bartsch DK
Ann Surg; 2013 Feb; 257(2):308-14. PubMed ID: 22580937
[TBL] [Abstract][Full Text] [Related]
27. Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1.
Waguespack SG
Front Endocrinol (Lausanne); 2022; 13():1029041. PubMed ID: 36325452
[TBL] [Abstract][Full Text] [Related]
28. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
31. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Lourenço DM; Coutinho FL; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
J Bone Miner Res; 2010 Nov; 25(11):2382-91. PubMed ID: 20499354
[TBL] [Abstract][Full Text] [Related]
32. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.
Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
[TBL] [Abstract][Full Text] [Related]
34. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
[TBL] [Abstract][Full Text] [Related]
35. [Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].
Anlauf M; Perren A; Klöppel G
Verh Dtsch Ges Pathol; 2007; 91():320-9. PubMed ID: 18314630
[TBL] [Abstract][Full Text] [Related]
36. Primary peripancreatic lymph node gastrinoma in a woman with MEN1.
Zhou H; Schweikert HU; Wolff M; Fischer HP
J Hepatobiliary Pancreat Surg; 2006; 13(5):477-81. PubMed ID: 17013727
[TBL] [Abstract][Full Text] [Related]
37. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
38. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
39. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor.
Anlauf M; Enosawa T; Henopp T; Schmitt A; Gimm O; Brauckhoff M; Dralle H; Musil A; Hauptmann S; Perren A; Klöppel G
Am J Surg Pathol; 2008 Jul; 32(7):1101-5. PubMed ID: 18520436
[TBL] [Abstract][Full Text] [Related]
40. Multiple endocrine neoplasia type 1 (MEN1).
Carroll RW
Asia Pac J Clin Oncol; 2013 Dec; 9(4):297-309. PubMed ID: 23279763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
